Blog

LED, IPL and laser: the three categories at a glance

Start with two questions: What produces the light? and what tissue effect is intended? A source name answers the first question, not the second. The FDA’s PBM draft explicitly includes both coherent laser sources and non-coherent sources such as LEDs. [1]

These distinctions come from the FDA’s PBM and laser explanations and DermNet’s IPL overview. A filtered IPL pulse still contains a range of wavelengths; it does not become a laser because a service calls it “laser hair removal.” [1] [2] [3] [8]

What happens in tissue matters as much as the source

Photobiomodulation: a nonthermal treatment approach

Photobiomodulation (PBM) is intended to change biological activity without using heating as the treatment mechanism. That does not guarantee zero warmth. It is not defined by an LED housing, a red glow or the absence of discomfort. Its mechanisms are not fully understood, and outcomes depend on the exposure and application. A low-level laser can be used for PBM, so “laser” does not automatically mean resurfacing. The FDA document describing this distinction remains a draft, not for implementation; it is not a treatment protocol. [1]

Selective heating: absorption directs the effect

In IPL and many cosmetic laser procedures, light is absorbed by a target, or chromophore, and converted to heat. Melanin and haemoglobin are relevant targets in hair, pigment and vascular applications. Selectivity depends on the wavelength or filter, pulse and treatment conditions; it does not mean that surrounding skin is immune to injury. [2] [6]

Ablation and fractional delivery describe different things

Ablative laser resurfacing removes tissue. Non-ablative approaches aim to produce effects without that removal. Fractional describes treatment in separated microscopic zones, and fractional systems can be ablative or non-ablative. It is therefore incomplete to compare an LED session with “fractional laser” without identifying which laser procedure is meant. [4]

Photodynamic therapy (PDT) is another distinct procedure: it combines light with a photosensitizing treatment. Evidence for PDT cannot be relabeled as evidence for ordinary LED exposure without that sensitizer. [7]

Compare the same outcome, not just the same body area

“For the face” is not a clinical endpoint. Before asking which technology works better, specify what change is being measured.

A study reporting satisfaction after red-light treatment cannot be ranked directly against a resurfacing study measuring scar depth. Nor does a biological mechanism prove a visible result. The AAD notes that red-light studies use different devices, exposures and research questions, limiting comparisons. This article does not establish a winner or clinical equivalence between the categories. [5]

How to identify what a service or device actually offers

Use the following questions as a document checklist. A missing answer is a reason to obtain information, not permission to improvise.

1. What is the exact device and applicator? Record the manufacturer, model and operating mode. A platform with several handpieces may offer several technologies.
2. What source reaches the treatment area? Ask whether it is LED, IPL or laser. For IPL, identify the filter; for a laser, identify the wavelength and procedure.
3. What effect is intended? Is the procedure PBM, selective heating, ablative resurfacing or PDT? “Photon therapy” or “photofacial” alone is insufficient.
4. What outcome is supported? Ask for human evidence relevant to the concern, device or justified equivalent, exposure, population and follow-up. A mechanism diagram is not a clinical trial.
5. What instructions and safety assessment apply? Obtain the current instructions for use, permitted areas, eye-protection requirements and restrictions. Provider experience should match the procedure and relevant skin types.
6. What does any regulatory claim actually cover? Check the exact model, intended use and jurisdiction. An LED or IPL product is not a laser under the FDA’s definition; that fact alone does not settle its medical-device status. [8]

For example, a service described as “laser photofacial” that uses an IPL handpiece should be evaluated as IPL. A laser described as “low level” still needs its own instructions and hazard controls. These are classification questions, not shortcuts to choosing settings.

Why safety, training and rules cannot be transferred

Laser beams can concentrate energy in the eye; visible brightness is not a reliable measure of laser power or eye hazard. LED exposure can also present an eye hazard depending on intensity and duration. “Non-ionizing” does not mean harmless. [3] [9]

There is no common schedule, distance, pulse setting or protective-eyewear specification that this comparison can supply. Likewise, competence with LED PBM does not by itself establish competence with IPL or ablative laser procedures. ARPANSA’s advice emphasizes procedure-related risks and provider competence; its 2018 advisory is not a current licensing map. Check the relevant local authority for the exact procedure and location. [6] [9]

Three common misconceptions

• “A narrower spectrum always gives better results.” Spectrum describes the source. It cannot replace evidence for the intended outcome.
• “Non-ablative means nonthermal.” Non-ablative IPL still uses heat; preserving the surface is different from avoiding intentional heating. [2]
• “A stronger sensation proves a stronger benefit.” Pain is not an efficacy measurement. Unexpected discomfort is a stop signal, not a target to pursue. [6]

Questions that labels do not answer

Is a diode laser the same as an LED?

No. “Diode” does not make the two source types interchangeable. Ask whether the output is a laser or a light-emitting diode source; the FDA explicitly distinguishes LEDs from lasers. [8]

Does “phototherapy” always mean red-light PBM?

No. It is a broad term. Even a laser can emit visible, infrared or ultraviolet radiation. Confirm the actual spectrum and procedure rather than applying red-light instructions to every light treatment. [3]

Can I add an LED session after IPL or laser?

This comparison cannot authorize that combination or specify a waiting period. A study of clinician-directed combined treatment does not establish permission for a different device on recently treated skin. Ask the treating clinician to reconcile both procedures with the current device instructions.

The useful distinction is source plus procedure

Identify the source, intended tissue effect and specific outcome. Then examine evidence, suitability and safety for that exact intervention. A clear treatment description should let you do all three without relying on a glowing color or an ambiguous service name.